WEGIO
LIVE

Serial Number

98559173

Owner

RCV GmbH

Attorney

Angela P. Doughty

Filing Date

May 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

WEGIO Trademark

Serial Number: 98559173 • Registration: 8027188

WEGIO is a trademark filed by RCV GmbH on May 20, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

RCV GmbH

Leibnizstrasse 58
Berlin 10629 , DE

Entity Type: 99

Trademark Details

Filing Date

May 20, 2024

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Organization and conducting of conferences, exhibitions and competitions for genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing; educational services, namely, training in the field of therapeutic treatments; educational services, namely, training in the field of pharmacy; educational services, namely, training in the field of medicine; Conducting training in the field of healthcare; Educational services, namely, conducting courses in the field of biological subjects; conducting medical training courses; conducting continuing medical education courses; Development and dissemination of printed educational materials of others in the field of genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing; Educational services, namely, conducting adult education classes in the medical field and the pharmaceutical field; medical training; providing on-line non-downloadable publications in the nature of journals, abstracts, laboratory reports, laboratory and genetic journals, hand books, metabolic instructions and reports on clinical trials in the field of genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing; organizing and conducting lectures in the field of genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing; Educational services, namely, conducting conferences, seminars, classes, presentations, workshops for medical professionals, scientist, and pharmaceutical companies in the fields of genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and testing, people suffering from obesity or at risk of suffering from obesity, and the early detection of genetic causes of obesity

Performing medical screenings; performing medical analysis for the diagnosis of obesity; medical analysis services for the diagnosis and prognosis of obesity; medical services, namely, performing RNA, DNA, antigen and epitope analysis for the diagnosis, prognosis and treatment recommendation of obesity; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient

Updating and maintenance of data in computer databases; Collecting and analyzing claims data from healthcare organizations for business purposes; Compilation and systematization of information into computer databases; database management; collection, updating, maintenance and systematization of data in the field of obesity therapy.

Downloadable computer programs for fault diagnosis, troubleshooting, remote control, registration and management of medical, veterinary and scientific apparatus and instruments; electronic publications, namely, journals, abstracts, laboratory reports, laboratory and genetic journals, hand books, metabolic instructions and reports on clinical trials featuring genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing recorded on computer media; downloadable computer software for the provision of data and information in the field of medical tests, analyses and diagnoses; Prerecorded magnetic data carriers featuring data and information in the field of medical or pharmacological tests, analyses and diagnoses; electronic databases in the field of information and data relating to medical tests, pharmacological tests, analyses and diagnoses.

Scientific research; scientific research for medical purposes in the field of genetics, obesity, early detection of genetic causes of obesity, whole genome sequencing and genetic testing; scientific research for medical purposes in the field of obesity; development, updating and maintenance of computer software and computer databases; provision of scientific research results; provision of scientific research information and research results via a database; provision of scientific research information and research results via a database; provision of scientific research information and research results via a searchable database; provision of scientific research information and research results via an online searchable database; medical and scientific research information provided via the Internet and Intranet; Compiling data for research purposes in the field of medical science and medical consultancy; Cancer research information; Conducting scientific feasibility studies in the field of pharmacology; Medical and scientific research, namely, conducting clinical trials for others in the field obesity, treatment and diagnosis of obesity; Platform as a Service [PaaS] featuring computer software platforms for provision of scientific and medical research results.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Sep 9, 2025 ISCR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 24, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 24, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 31, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2024 NWOS
NEW APPLICATION ENTERED
May 20, 2024 NWAP